Small-animal PET imaging performed to evaluate the potential of 64Cu-PCTA-cetuximab as an immuno-PET imaging agent for EGFR expression level in SNU-1066 tumor-bearing mice (Figure 3). This evidence concerns the gene EGFR and neoplasm.